PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence
- PMID: 14759723
- DOI: 10.1016/j.breast.2003.09.008
PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence
Abstract
The proto-oncogene pituitary tumor-transforming gene (PTTG) is described as abundantly overexpressed in a variety of neoplasms and cancer cell lines. We analyzed PTTG mRNA expression in 72 tumor samples derived from primary tumors of patients suffering from breast cancer and in unaffected breast epithelium, checking for correlations between expression levels and standard clinico-pathological parameters over a 5-year observation period. We found a direct correlation between PTTG mRNA overexpression and lymph node infiltration. Furthermore, overexpression of this gene in tumors correlated with a higher degree of tumor recurrence within the subsequent observation period. Taken together, these results demonstrate that determination of PTTG expression in primary tumors of the breast is a powerful tool for the assessment of potential tumor aggressiveness.
Similar articles
-
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.Breast Cancer Res Treat. 2007 Mar;101(3):259-67. doi: 10.1007/s10549-006-9296-7. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821081
-
Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.BMC Cancer. 2006 Oct 9;6:242. doi: 10.1186/1471-2407-6-242. BMC Cancer. 2006. PMID: 17029632 Free PMC article.
-
Survivin expression predicts early recurrence in early-stage breast cancer.Anticancer Res. 2007 Jul-Aug;27(4C):2803-8. Anticancer Res. 2007. PMID: 17695451
-
Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.Endocr Relat Cancer. 2008 Sep;15(3):721-43. doi: 10.1677/ERC-08-0012. Endocr Relat Cancer. 2008. PMID: 18753362 Review.
-
Pituitary tumor-transforming gene and its binding factor in endocrine cancer.Expert Rev Mol Med. 2010 Dec 3;12:e38. doi: 10.1017/S1462399410001699. Expert Rev Mol Med. 2010. PMID: 21129230 Review.
Cited by
-
Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.Int J Med Sci. 2020 Oct 22;17(18):3112-3124. doi: 10.7150/ijms.49652. eCollection 2020. Int J Med Sci. 2020. PMID: 33173433 Free PMC article.
-
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.Cancer Res. 2008 May 1;68(9):3214-24. doi: 10.1158/0008-5472.CAN-07-3043. Cancer Res. 2008. PMID: 18451147 Free PMC article.
-
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.Breast Cancer Res. 2012 Jul 12;14(4):R106. doi: 10.1186/bcr3226. Breast Cancer Res. 2012. PMID: 22789011 Free PMC article.
-
Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.Mol Cancer. 2005 Jan 13;4(1):3. doi: 10.1186/1476-4598-4-3. Mol Cancer. 2005. PMID: 15649325 Free PMC article.
-
MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.Am J Transl Res. 2017 Nov 15;9(11):4872-4887. eCollection 2017. Am J Transl Res. 2017. PMID: 29218086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical